Human Longevity

Human Longevity Inc. (HLI) is a genomics and cell therapy-based diagnostic and therapeutic company. Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building a comprehensive database on human genotypes and phenotypes to tackle the diseases associated with aging-related human biological decline. HLI is also leading the development of cell-based therapeutics to address age-related decline in endogenous stem cell function. HLI is concentrating on cancer, diabetes and obesity, heart and liver diseases, and dementia.
Company Growth (employees)
San Diego, US
Size (employees)
249 (est)-6%
Human Longevity was founded in 2013 and is headquartered in San Diego, US

Key People/Management at Human Longevity

Craig Venter

Craig Venter

William Roper

William Roper

Robert Hariri

Robert Hariri

Co-Founder, President
William Biggs

William Biggs

Head, Genomic Sequencing
Kenneth Bloom

Kenneth Bloom

Head of Oncology

Human Longevity Office Locations

Human Longevity has offices in San Diego, Mountain View and Singapore
San Diego, US (HQ)
4570 Executive Dr
Mountain View, US
100 View St

Human Longevity Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$580.5 m

Latest funding size

$500 m

Time since last funding

over 1 year


Human Longevity's latest funding round in April 2016 was reported to be $500 m. In total, Human Longevity has raised $580.5 m. Human Longevity's latest valuation is reported to be $1.2 b.

Human Longevity Financials


Market valuation

1.2 b
Show all financial metrics

Human Longevity's Web-traffic and Trends

Human Longevity Online and Social Media Presence

Human Longevity News and Updates

Human Longevity chief says genome sequencing can help people cheat death

J. Craig Venter’s company tests healthy consumers, something that’s not been done before, he says.

Human Longevity Company Life and Culture

You may also be interested in